VAM
SGYP

Visium Asset Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Visium Asset Management’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,030
Closed -$340K – 1290
2015
Q2 		$340K Buy
+1,030
New +$4.99K ﹤0.01% 760

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Visium Asset Management's SGYP Position: Q3 2016 in Review

Visium Asset Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q3 2016, closing a stake of 118,753 shares — an estimated $451K sold.

Visium Asset Management first reported a position in SGYP in Q2 2016 and held it in 1 quarter. The position peaked at $451K in Q2 2016. 149 funds tracked by Wall St. Rank hold SGYP as of Q3 2016.

  • Visium Asset Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q3 2016 after selling out during the quarter.
  • Visium Asset Management sold 118,753 Synergy Pharmaceuticals, Inc Common Stock shares in Q3 2016, an estimated $451K.
  • Visium Asset Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2016 and held it in 1 quarter.
  • Visium Asset Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $451K in Q2 2016.
  • 149 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2016.

Based on Visium Asset Management's 13F filing for Q3 2016.